GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » WDB coco Co Ltd (TSE:7079) » Definitions » EV-to-Revenue

WDB coco Co (TSE:7079) EV-to-Revenue : 1.30 (As of May. 27, 2024)


View and export this data going back to 2019. Start your Free Trial

What is WDB coco Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, WDB coco Co's enterprise value is 円5,706 Mil. WDB coco Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was 円4,386 Mil. Therefore, WDB coco Co's EV-to-Revenue for today is 1.30.

The historical rank and industry rank for WDB coco Co's EV-to-Revenue or its related term are showing as below:

TSE:7079' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.2   Med: 3   Max: 11.33
Current: 1.31

During the past 6 years, the highest EV-to-Revenue of WDB coco Co was 11.33. The lowest was 1.20. And the median was 3.00.

TSE:7079's EV-to-Revenue is ranked better than
63.2% of 663 companies
in the Healthcare Providers & Services industry
Industry Median: 1.86 vs TSE:7079: 1.31

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-27), WDB coco Co's stock price is 円3195.00. WDB coco Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was 円1,822.57. Therefore, WDB coco Co's PS Ratio for today is 1.75.


WDB coco Co EV-to-Revenue Historical Data

The historical data trend for WDB coco Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WDB coco Co EV-to-Revenue Chart

WDB coco Co Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-Revenue
Get a 7-Day Free Trial - 2.02 3.20 3.08 2.37

WDB coco Co Quarterly Data
Mar18 Mar19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.88 2.37 3.21 2.47 2.03

Competitive Comparison of WDB coco Co's EV-to-Revenue

For the Health Information Services subindustry, WDB coco Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


WDB coco Co's EV-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, WDB coco Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where WDB coco Co's EV-to-Revenue falls into.



WDB coco Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

WDB coco Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=5706.010/4385.641
=1.30

WDB coco Co's current Enterprise Value is 円5,706 Mil.
WDB coco Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円4,386 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


WDB coco Co  (TSE:7079) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

WDB coco Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=3195.00/1822.573
=1.75

WDB coco Co's share price for today is 円3195.00.
WDB coco Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円1,822.57.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


WDB coco Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of WDB coco Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


WDB coco Co (TSE:7079) Business Description

Traded in Other Exchanges
N/A
Address
1-8-11 Harumi, Chuo-ku, Triton Square Y 27th Floor, Tokyo, JPN, 104-6127
WDB coco Co Ltd is a provider of safety information management for the development of pharmaceuticals and medical devices. Its services include business related to safety information management, preparation of materials related to regulatory application, QC related work, PMS facility contract support related work, clinical research support / monitoring, and temporary staffing. The company provides Contract Research Organization services for all new drug developments such as monitoring, safety information, data management and statistical analysis. It provides support for the development of generic drugs such as bioequivalence studies and biosimilars, clinical research and physician-led clinical trials.

WDB coco Co (TSE:7079) Headlines

No Headlines